Composition of bacteroides thetaiotaomicron for immune modulation
US11723933B2 · kind B2 · utility
0Cited by
50References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2019 |
| Grant date | Aug 15, 2023 |
| Priority date | — |
| Expiry date | Jun 12, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/01
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a strain of Bacteroides thetaiotaomicron and derivatives thereof, and the use of said strain or derivatives in treating inflammatory, autoimmune and allergic disorders. The invention also provides pharmaceutical compositions, nutritional supplements, feedstuffs, food products, dietary supplements, and food additives comprising said strain or derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.